Ngā hua rapu kaituhi

1

Venous Thromboembolism in Brain Tumors: Risk Factors, Molecular Mechanisms, and Clinical Challenges mā Julia Riedl, Cihan Ay

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer mā Florian Moik, Cihan Ay

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Gene therapy: principles, challenges and use in clinical practice mā Cihan Ay, Andreas Reinisch

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Biomarkers for prediction of venous thromboembolism in cancer mā Ingrid Pabinger, J. Thaler, Cihan Ay

I whakaputaina 2013

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence mā Stephan Nopp, Daniel Kraemmer, Cihan Ay

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants mā Cihan Ay, Jan Beyer‐Westendorf, Ingrid Pabinger

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Venous thrombosis and cancer: from mouse models to clinical trials mā Yohei Hisada, Julia E. Geddings, Cihan Ay, Nigel Mackman

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies mā Florian Moik, Jakob M. Riedl, Cornelia Englisch, Cihan Ay

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality mā Cihan Ay, Florian Posch, Alexandra Kaider, Christoph Zielinski, Ingrid Pabinger

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants mā Florian Posch, Oliver Königsbrügge, Christoph Zielinski, Ingrid Pabinger, Cihan Ay

I whakaputaina 2015

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized con... mā Florian Moik, Florian Posch, Christoph Zielinski, Ingrid Pabinger, Cihan Ay

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis mā Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical... mā Florian Moik, Gudrun Absenger, Robert Wurm, Maximilian J. Hochmair, Cihan Ay

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb mā Thomas Gremmel, Cihan Ay, Daniela Seidinger, Ingrid Pabinger, Simon Panzer, Renate Koppensteiner

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH mā Aurélien Delluc, Darko Antić, Ramón Lecumberri, Cihan Ay, Guy Meyer, Marc Carrier

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Human pancreatic tumors grown in mice release tissue factor‐positive microvesicles that increase venous clot size mā Yohei Hisada, Cihan Ay, Alyson C. Auriemma, Brian C. Cooley, Nigel Mackman

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

ABO blood group type and risk of venous thromboembolism in patients with cancer mā Cornelia Englisch, Florian Moik, Stephan Nopp, Markus Raderer, Ingrid Pabinger, Cihan Ay

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review mā Florian Moik, Meaghan Colling, Isabelle Mahé, Luis Jara‐Palomares, Ingrid Pabinger, Cihan Ay

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Venous thromboembolism a manifestation of the metabolic syndrome mā Cihan Ay, Theres Tengler, Rainer Vormittag, Ralph Simanek, Wolfgang Dorda, Thomas Vukovich, Ingrid Pabinger

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank mā Dino Mehic, Georg Neubauer, Florian Janig, Alexandra Kaider, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Cihan Ay

Venous Thromboembolism in Brain Tumors: Risk Factors, Molecular Mechanisms, and Clinical Challenges mā Julia Riedl, Cihan Ay

Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer mā Florian Moik, Cihan Ay

Gene therapy: principles, challenges and use in clinical practice mā Cihan Ay, Andreas Reinisch

Biomarkers for prediction of venous thromboembolism in cancer mā Ingrid Pabinger, J. Thaler, Cihan Ay

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence mā Stephan Nopp, Daniel Kraemmer, Cihan Ay

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants mā Cihan Ay, Jan Beyer‐Westendorf, Ingrid Pabinger

Venous thrombosis and cancer: from mouse models to clinical trials mā Yohei Hisada, Julia E. Geddings, Cihan Ay, Nigel Mackman

Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies mā Florian Moik, Jakob M. Riedl, Cornelia Englisch, Cihan Ay

Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality mā Cihan Ay, Florian Posch, Alexandra Kaider, Christoph Zielinski, Ingrid Pabinger

Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants mā Florian Posch, Oliver Königsbrügge, Christoph Zielinski, Ingrid Pabinger, Cihan Ay

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized con... mā Florian Moik, Florian Posch, Christoph Zielinski, Ingrid Pabinger, Cihan Ay

Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis mā Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay

Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical... mā Florian Moik, Gudrun Absenger, Robert Wurm, Maximilian J. Hochmair, Cihan Ay

Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb mā Thomas Gremmel, Cihan Ay, Daniela Seidinger, Ingrid Pabinger, Simon Panzer, Renate Koppensteiner

Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH mā Aurélien Delluc, Darko Antić, Ramón Lecumberri, Cihan Ay, Guy Meyer, Marc Carrier

Human pancreatic tumors grown in mice release tissue factor‐positive microvesicles that increase venous clot size mā Yohei Hisada, Cihan Ay, Alyson C. Auriemma, Brian C. Cooley, Nigel Mackman

ABO blood group type and risk of venous thromboembolism in patients with cancer mā Cornelia Englisch, Florian Moik, Stephan Nopp, Markus Raderer, Ingrid Pabinger, Cihan Ay

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review mā Florian Moik, Meaghan Colling, Isabelle Mahé, Luis Jara‐Palomares, Ingrid Pabinger, Cihan Ay

Venous thromboembolism a manifestation of the metabolic syndrome mā Cihan Ay, Theres Tengler, Rainer Vormittag, Ralph Simanek, Wolfgang Dorda, Thomas Vukovich, Ingrid Pabinger

Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank mā Dino Mehic, Georg Neubauer, Florian Janig, Alexandra Kaider, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Ngā utauta rapu:

Ngā marau whai pānga